Brief: ARS Pharmaceuticals Announces Filings For Approval Of Neffy In China, Japan And Australia
12/12/2024 19:54
Dec 12 (Reuters) - ARS Pharmaceuticals Inc SPRY.O :
* ARS PHARMACEUTICALS ANNOUNCES FILINGS FOR APPROVAL OF
NEFFY® IN
CHINA, JAPAN AND AUSTRALIA
Source text: ID:nGNXbFTvkV
Further company coverage: SPRY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ARS Pharmaceuticals
See all newsARS Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
ARS Pharmaceuticals Q2 neffy revenue rises as epinephrine market share doubles
U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
ARS Pharma tumbles as allergy nasal spray faces insurance coverage hurdle